Litigation for DYMISTA

US Court Litigation for DYMISTA

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
8,163,723		1:14-cv-01453|D. Del.	2014-12-02	2017-05-17	28:2201 Declaratory Judgment	District Court, D. Delaware	None
8,163,723	Meda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.	1:15-cv-00785|D. Del.	2015-09-08	2017-07-28	35:0145	District Court, D. Delaware	None
8,163,723	Meda Pharmaceuticals Inc. v. Perrigo UK FINCO Limited Partnership	1:16-cv-00794|D. Del.	2016-09-09	2017-07-07	35:271 Patent Infringement	District Court, D. Delaware	None
8,163,723	Meda Pharmaceuticals Inc. v. Perrigo UK FINCO Limited Partnership	1:16-cv-00794|D. Del.	2016-09-09	2017-07-07	35:271 Patent Infringement	District Court, D. Delaware	None
8,168,620		1:14-cv-01453|D. Del.	2014-12-02	2017-05-17	28:2201 Declaratory Judgment	District Court, D. Delaware	None

Patent Trial and Appeal Board Cases for DYMISTA

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
8,163,723	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC		2020-01-31	01-31-2020		Inter partes review		07-31-2020
8,168,620	Argentum Pharmaceuticals LLC		2017-02-02	02-02-2017	Lulla et al	Inter partes review		08-21-2017
8,168,620	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC		2020-01-31	01-31-2020		Inter partes review		07-31-2020
9,259,428	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC		2020-01-31	01-31-2020		Inter partes review		07-31-2020
9,901,585	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC		2020-01-31	01-31-2020		Inter partes review		07-31-2020